Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oculight is a South Korea-based ophthalmic medical device company focused on surgical tools and illumination systems for eye surgery, particularly cataract and retinal procedures. Founded in 2017 by ophthalmic surgeon Dr. Dong Heun Nam, the company is best known for the iChopper, an illuminated chopper for cataract surgery, and iVision, a dedicated LED light source used together in its SmartBeam approach. Oculight has positioned itself as an ophthalmology device innovator rather than a therapeutics developer, with products aimed at improving intraoperative visualization, surgical precision, and workflow. The company has also established a U.S. subsidiary, OCU L&C, to support commercialization in the United States. Available public information indicates Oculight is a private, venture-backed, actively operating medical device company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oculight.